|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.25 EUR | 0.00% |
|
-2.58% | +20.55% |
| 08-03 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
| 08-03 | Is Everything Under Control? |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.39% | -6.36% | -7.62% | +16.40% | +4.34% | +47.10% | +149.66% | +338.05% | +1,255.61% | 1T | ||
| -0.76% | -4.34% | -3.28% | +11.98% | +22.93% | +52.04% | +49.09% | +45.89% | +105.33% | 613B | ||
| -2.33% | -4.60% | -6.12% | +18.64% | +7.27% | +25.55% | +64.44% | +110.84% | +268.18% | 433B | ||
| +1.17% | -2.50% | +8.11% | +13.33% | +9.29% | +40.67% | +35.33% | +1.33% | +45.99% | 350B | ||
| +2.04% | -9.46% | -16.91% | -12.11% | -15.04% | +5.21% | +7.39% | +41.67% | +127.36% | 239B | ||
| +2.41% | -7.93% | -3.83% | +9.14% | -5.06% | -1.34% | -41.82% | +1.08% | +68.28% | 206B | ||
| -1.63% | +0.69% | +1.26% | +14.87% | +15.75% | +27.62% | +64.23% | +55.22% | +118.46% | 204B | ||
| +0.72% | +0.48% | -0.09% | -0.38% | +6.85% | +15.88% | +73.64% | +87.81% | +63.75% | 163B | ||
| +0.08% | +1.46% | +2.92% | -4.94% | +0.52% | +6.56% | -28.49% | -45.21% | -29.07% | 143B | ||
| +0.24% | +4.65% | +12.63% | +12.45% | +21.38% | +48.02% | +6.92% | -5.54% | -12.47% | 134B | ||
| -1.34% | -1.73% | -10.86% | +11.04% | +3.83% | +1.86% | +35.37% | +135.30% | +368.66% | 119B | ||
| +0.45% | -5.80% | -3.62% | +2.92% | +4.75% | +36.66% | +41.89% | +6.65% | -10.01% | 103B | ||
| -0.34% | -6.46% | -0.35% | -4.58% | -10.24% | -9.45% | -20.94% | -12.13% | +2.06% | 103B | ||
| -0.10% | -4.56% | -11.42% | -17.48% | -18.96% | -8.53% | +62.25% | +67.63% | +447.54% | 70.18B | ||
| -2.26% | -7.97% | -4.19% | -0.45% | +9.33% | +25.29% | +21.69% | +46.02% | +11.66% | 55.08B | ||
| +4.79% | +5.46% | -3.09% | +32.62% | +34.02% | +80.40% | -3.91% | -0.45% | -47.21% | 53.26B | ||
| -2.00% | -1.12% | -2.66% | -1.63% | -11.03% | -13.55% | +25.38% | -7.67% | +226.04% | 51.77B | ||
| -0.97% | -5.83% | +0.05% | +7.39% | -4.30% | +0.81% | +11.48% | - | - | 42.85B | ||
| -1.57% | +10.88% | -0.52% | -1.40% | +10.41% | +124.06% | +260.08% | +247.38% | -35.67% | 40.16B | ||
| Average | -0.01% | -1.81% | -2.61% | +5.67% | +4.53% | +26.57% | +42.82% | +61.88% | +165.25% | 217.02B | |
| Weighted average by Cap. | +0.16% | -3.52% | -3.64% | +10.00% | +6.79% | +32.32% | +62.85% | +116.56% | +394.25% |
- Stock Market
- Stocks
- NOVN Stock
- NOVN Stock
- Sector Novartis
Select your edition
All financial news and data tailored to specific country editions
















